tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (DE:08HH)
FRANKFURT:08HH

Shanghai Fosun Pharmaceutical (Group) Co (08HH) Revenue

0 Followers

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 20.10B in the quarter ending Jun 30, 2026, with 99.49%. This bring the company's revenue in the last twelve months to 61.75B, Decreased 19.33%. In the fiscal year ending Dec 31, 2025, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 40.42B with -1.57% growth.
Revenue (ttm)
61.75B
Revenue Growth
2.13%
P/S Ratio
0.17
Revenue/Employee
€995,599
Employees
40,603
Market Cap
€6.90B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
40.42B-642.89M-1.57%
Dec 31, 2024
41.07B-332.34M-0.80%
Dec 31, 2023
41.40B-2.55B-5.81%
Dec 31, 2022
43.95B4.95B+12.68%
Dec 31, 2021
39.01B8.70B+28.70%
Dec 31, 2020
30.31B1.72B+6.02%
Dec 31, 2019
28.59B3.67B+14.72%
Dec 31, 2018
24.92B6.38B+34.45%
Dec 31, 2017
18.53B